Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio A Urbina

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Acta Tropica|November 11, 2009
Specific chemotherapy of Chagas disease: relevance, current limitations and new approachesJulio A Urbina
Memorias Do Instituto Oswaldo Cruz|September 16, 2009
Ergosterol biosynthesis and drug development for Chagas diseaseJulio A Urbina
The Journal of Eukaryotic Microbiology|October 7, 2014
Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectivesJulio A Urbina
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 26, 2006
Mechanisms of action of lysophospholipid analogues against trypanosomatid parasitesJulio A Urbina
Current Pharmaceutical Design|February 28, 2002
Chemotherapy of Chagas diseaseJulio A Urbina
International Journal for Parasitology. Drugs and Drug Resistance|January 2, 2013
Recent Developments in Sterol 14-demethylase Inhibitors for Chagas DiseaseFrederick S Buckner, Julio A Urbina
Trends in Parasitology|September 10, 2005
Chemotherapy of trypanosomiases and leishmaniasisSimon L Croft, Michael P Barrett, Julio A Urbina
International Journal of Antimicrobial Agents|July 1, 2004
Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruziMarina V Braga, Julio A Urbina, Wanderley de Souza
Experimental Parasitology|June 3, 2004
The glycosome membrane of Trypanosoma cruzi epimastigotes: protein and lipid compositionWilfredo Quiñones, Julio A Urbina, Michel Dubourdieu, et al.
Experimental Parasitology|October 4, 2005
Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensisJuliany C F Rodrigues, Julio A Urbina, Wanderley de Souza
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Acta Tropica|November 11, 2009
Specific chemotherapy of Chagas disease: relevance, current limitations and new approachesJulio A Urbina
Memorias Do Instituto Oswaldo Cruz|September 16, 2009
Ergosterol biosynthesis and drug development for Chagas diseaseJulio A Urbina
The Journal of Eukaryotic Microbiology|October 7, 2014
Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectivesJulio A Urbina
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 26, 2006
Mechanisms of action of lysophospholipid analogues against trypanosomatid parasitesJulio A Urbina
Current Pharmaceutical Design|February 28, 2002
Chemotherapy of Chagas diseaseJulio A Urbina
International Journal for Parasitology. Drugs and Drug Resistance|January 2, 2013
Recent Developments in Sterol 14-demethylase Inhibitors for Chagas DiseaseFrederick S Buckner, Julio A Urbina
Trends in Parasitology|September 10, 2005
Chemotherapy of trypanosomiases and leishmaniasisSimon L Croft, Michael P Barrett, Julio A Urbina
International Journal of Antimicrobial Agents|July 1, 2004
Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruziMarina V Braga, Julio A Urbina, Wanderley de Souza
Experimental Parasitology|June 3, 2004
The glycosome membrane of Trypanosoma cruzi epimastigotes: protein and lipid compositionWilfredo Quiñones, Julio A Urbina, Michel Dubourdieu, et al.
Experimental Parasitology|October 4, 2005
Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensisJuliany C F Rodrigues, Julio A Urbina, Wanderley de Souza
Pageof 7